Konferenzen  >  Biowissenschaften  >  Systembiologie und mathematische Biologie

Oxford Global

Join NextGen Biomed 2025 to connect with 1,000+ experts in Proteins, Peptides, Oligonucleotides, Vaccines, Immunotherapy & Sustainability. Discover breakthroughs, attend panels, and network to drive life-saving innovation.

Brand and Content Manager;     Email: c.donohoe@oxfordglobal.com

Vaccines, Peptides, Oligonucleotides, Antibodies, Biomedicine, Immunotherapy, Immuno-oncology, ACD's, Sustainability, Proteins,

Biotechnologie,    Genomforschung und Bioinformatik

Institute for Computational and Experimental Research in Mathematics, Brown University, Providence, RI (ICERM)

Mathematical models play a vital role in understanding complex biological systems. However, these systems are often characterized by indirectly and partially observed, noisy, and high-dimensional dynamics and data. Current models often fail to adequately account for the various sources of uncertainty within the data, leading to inaccurate or incomplete models with limited explanatory power. The field of uncertainty quantification (UQ) offers approaches to address these challenges.

Singularity University

In May 2025 in San Diego, we will host experts, innovators, and executives from diverse industries to explore and shape the future of biotech-driven innovation.

Singularity Programs Team;     Tel.: [1-650-200-3434];     Email: programs@su.org

AI, Bio-informed innovation, Wast-to-value, Micro-bio Workforce, Digital Biology, Bio-Mining, Bio-energy, Bio-Manufacturing, Future of Food

Biotechnologie,    Genomforschung und Bioinformatik

European Molecular Biology Organization (EMBO)

European Molecular Biology Organization (EMBO)

Molekularbiologie,    Wissenschaftliches Rechnen und Datenwissenschaft

Luxembourg Centre for Systems Biomedicine, University of Luxembourg

The 8th edition of this international meeting on Neuroinflammation will focus on the theme “Cerebral immune activation at the crossroads of healthy aging, senescence and neurodegeneration” encompassing basic, clinical, methodological and emerging perspectives and including internationally renowned scientists with expertise across a wide range of domains, as main speakers. The conference offers new grounds for scientific exchange, joint strategies and collaborative actions within the Neuroinflammation community on an international level.

Email: lcsb.events@uni.lu

neuroinflammation, neurodegeneration, neurodegenerative diseases, alzheimer's disease, brain, healthy aging,

Translationale Medizin, Klinische Studien,    Neurologie

The European Association for Cancer Research (EACR) and The Mark Foundation for Cancer Research

Early-onset cancers are rising globally. Cancers typically associated with those over the age of 50 are increasingly being diagnosed in young adults. How to prevent and treat these tumours is still unknown. This conference aims to foster a deeper understanding of the biological mechanisms, risk factors, and clinical implications of early-onset cancers. By bringing together leading experts from diverse fields in cancer research, the meeting will provide a unique platform to discuss the latest discoveries about early-onset cancers, promoting interdisciplinary collaboration and identifying strategies for early detection, prevention, and treatment. Special attention will be given to knowledge gaps, translational studies and healthcare disparities, and towards improving the clinical management of early-onset cancer patients. The target audience for this conference is researchers and physicians who are interested in the epidemiology and aetiology of sporadic cancers among younger adults to discuss key questions in the field and lay the foundations for generating a community dedicated to the study of early-onset cancers.

Conference Officer, Hannah Barrs;     Tel.: [N/A];     Email: hannah.barrs@eacr.org

cancer research, oncology, early-onset cancers, biological mechanisms of cancer, cancer risk factors, clinical implications, early detection, prevention, cancer treatment, cancer therapies, healthcare disparities, translational cancer research, clinical management of cancer patients, cancer epidemiology, cancer aetiology, molecular pathology, exposome changes, cancer microbiome, cancer immunity, the tumour microenvironment, carcinogenesis, cancer epigenetics, preclinical experimental models, microsimulation modelling, cancer, cancer survivorship.

Onkologie,    Molekularbiologie